SCHEMBL17508366

SCHEMBL17508366

c1ccc(-c2ccc(-c3ncnc4nccnc34)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.43
DHODH Q02127 1/20 0.40
ADK P55263 1/20 0.39
CDK5 Q00535 1/20 0.39
CDK5R1 Q15078 1/20 0.39
JAK2 O60674 1/20 0.39
ALDH1A1 P00352 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PIK3CD O00329 1/20 0.37
PIK3CA P42336 1/20 0.37
PIK3CB P42338 1/20 0.37
PIK3CG P48736 1/20 0.37
PRKDC P78527 1/20 0.37
HTT P42858 2/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
MAPK1 P28482 1/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27997621 0.96 ADORA2A (0.46) ADORA2ADHODHADKCDK5CDK5R1
SCHEMBL17508367 0.88 PIK3CG (0.40) ADORA2ACDK5CDK5R1PIK3CDPIK3CA
SCHEMBL27997390 0.80 MAPK9 (0.49) ADORA2AJAK2PIK3CDPIK3CAPIK3CB
SCHEMBL16218737 0.76 ADORA2A (0.55) ADORA2ADHODHJAK2ALDH1A1MEN1
SCHEMBL17522834 0.74 KDM4E (0.50) ADORA2ADHODHCDK5CDK5R1ALDH1A1
SCHEMBL14525924 0.73 ALDH1A1 (0.50) ADORA2AALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL14525863 0.73 ALDH1A1 (0.50) ADORA2AALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL27997397 0.71 SMN1; SMN2 (0.44) ALDH1A1KMT2ASMN1; SMN2LMNATP53
SCHEMBL30290940 0.70 PIK3CA (0.43) PIK3CDPIK3CAPIK3CBPIK3CGMAP4K4
SCHEMBL14983464 0.69 PIK3CG (0.65) ADORA2AADKALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9676767-B2 Indoloacridine-containing derivative, preparation process and use thereof, and organic luminescent device BOE TECHNOLOGY GROUP CO., LTD. (CN) 2017-06-13 US disclosed
US-20160046621-A1 INDOLOACRIDINE-CONTAINING DERIVATIVE, PREPARATION PROCESS AND USE THEREOF, AND ORGANIC LUMINESCENT DEVICE BOE TECHNOLOGY GROUP CO., LTD. (CN) 2016-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160046621-A1 INDOLOACRIDINE-CONTAINING DERIVATIVE, PREPARATION PROCESS AND USE THEREOF, AND ORGANIC LUMINESCENT DEVICE AHR, CDYL, SLC18A1 ADORA2A 101/4885DHODH 2327/4885ADK 345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.